Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has informed the exchange that its trading window is closed in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. This means insiders, including directors and employees, are restricted from trading the company's shares during this period. The closure is typically triggered by upcoming corporate announcements such as financial results.
This is a routine regulatory filing with no direct impact on shareholders or stock price. Investors should note that no insider trading can occur during this window, which usually precedes a material announcement like quarterly results.